The ACTIV-4 Host Tissue clinical trial platform, which is designed to investigate therapies targeting the host tissue response to COVID-19 to mitigate lung injury, is now being expanded internationally.

Three physicians in the Vanderbilt Department of Pediatrics have been elected to the American Pediatric Society.

A new approach for conducting gene-based analyses for cancer susceptibility created at Vanderbilt outperforms existing models.

With the development of new variants of the COVID-19 virus across the U.S. and the world, Vanderbilt University Medical Center recommends getting the bivalent booster vaccination.

A new study shows that a tool developed at Vanderbilt University Medical Center to address disrespectful workplace behaviors through trained peer-to-peer messaging can be successfully implemented in the nursing workforce with the appropriate support.

Vanderbilt's Kyla Terhune, MD, MBA, Vice President for Educational Affairs and Associate Dean for Graduate Medical Education, has been named Senior Vice President for Educational Affairs.

John H. Exton, MBChB, MD, PhD, professor of Molecular Physiology and Biophysics, emeritus at Vanderbilt University, whose research provided fundamental insights into how many biologically active compounds control cellular physiology, died Dec. 18. He was 89.